Arkolith/Insider Trading/AXNX/Form 4

Noblett Karen

Chief Medical OfficerAxonics, Inc. (AXNX) · full profile →Form 4 · filed Jan 10, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.1M
Net Open-Market Flow
-$1.1M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 8, 2024Sell(S)16K$69.00$1.1M18K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001562180-24-000425) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML